the fact is RXMD increased the shares to 66millon for a dilution with possibility of a reverse split that alone is killing the stock.
It is silly for anyone to be concerned about a reverse split at this time. They are a ways off from an uplist to the NASDAQ. When we get closer to that date, a R/S will be a legit concern, unless you are looking forward to a NASDAQ listing. (See Net Element)
The additional dilution by the company was unfortunate ($4,000,000), BUT you have to give them kudos for keeping the O/S stable for the past 2 years.